Schedule 13D ownership disclosure
Cartesian Therapeutics Inc
Common Stock, $0.0001 par value per share · CUSIP: 816212302
Event date: 2024-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Timothy A. SpringerReported CIK 0001055624
Shares: 9,534,216.00 · Class: 36.8%
- TAS Partners LLCReported CIK 0001677543
Shares: 563,206.00 · Class: 2.2%
- Chafen Lu
Shares: 350,740.00 · Class: 1.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-112113
- Form type
- SCHEDULE 13D/A
- Filer
- Cartesian Therapeutics, Inc.
- CIK
- CIK 1453687
- Filed
- Dec 23, 2024
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13D beneficial ownership